Comparative efficacy of hydroxychloroquine and griseofulvin in the treatment of lichen planus

Authors

  • Ishrat Bhuiyan Department of Dermatology & Venereology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
  • M A Wahab Department of Dermatology & Venereology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
  • Ahammed Ali Department of Dermatology & Venereology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
  • Abida Sultana Department of Dermatology & Venereology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
  • Rahmat Ullah Siddique Department of Dermatology & Venereology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
  • Abdur Rob Hawlader Department of Respiratory Medicine, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
  • Nasrin Sultana Monamie Department of Dermatology & Venereology, BIHS Hospital, Darussalam, Mirpur, Dhaka

DOI:

https://doi.org/10.66344/jpad.v20i2.424

Keywords:

Lichen planus, hydroxychloroquine, griseofulvin

Abstract

Background Lichen planus (LP) is an unpredictable disease that typically persists for 1 to 2 years, but which may follow a chronic, relapsing course over many years. Management of LP can be challenging and discouraging for both the patient and physician.

Objectives To compare the efficacy of hydroxychloroquine and griseofulvin in the treatment of LP.

Patients and methods 80 cases of age group 20-60 years were selected for the study during the period of July 2007 to June 2009 in the Department of Dermatology and Venereology of three different hospitals in Bangladesh. All cases were diagnosed clinically and confirmed by histopathological examination of skin. The patients were randomly divided into 2 equal groups. Group A was given hydroxychloroquine 400 mg daily and group B was given griseofulvin 500mg daily for a period of 6 months.

Results 53 (66%) male and 27 (34%) female were included in the study. The mean age in group A was 39.03±12.28 years and in group B was 42.87±11.16 years (p=0.146). The mean duration of the disease in group A was 4.37±3.87 months and in group B was 4.35±3.32 months (p=0.975). In group A clinical responders were 28 (70%): complete response in 7 (17.5%) and moderate improvement in 21 (52.5%) and in group B clinical responders were 17 (42.5%): complete response in 2 (5%) and moderate improvement in 15 (37.5%) [p=0.027].

Conclusion In this study both hydroxychloroquine and griseofulvin showed clinical improvement but hydroxychloroquine showed a relatively better response than griseofulvin in the treatment of LP.

 

References

1. Odom RB; James WD; Trimothy GB, eds. Anderw's Diseases of the Skin, 10th edn. Philadelphia: WB Saunders; 2000. pp. 217-230.

2. Katta R. Lichen planus. Am Fam Physician 2000; 61: 3319-24, 3327-8.

3. Pittelkow MR, Daoud MS. Lichen planus. In: Wolff K, Goldsmith LA, Katz SI et al., eds. Fitzpatrick's Dermatology in General Medicine, 7th edn. New York: McGraw-Hill; 2008. p. 244-55.

4. Sehgal VN, Bikhehandani R, Koranne RV et al. Histological evaluation of griseofulvin therapy in lichen planus: a double blind controlled study. Dermatologica 1980; 161:22-7.

5. Levy A, Stempler U, Yuzuk S et al. Lichen planus. J Dermatol 1986; 25: 405-7.

6. Royd AS, Neldner KH. Lichen planus. J Am Acad Dermatol 1991; 25: 593-619.

7. Araujo OE, Flowers FP, King MM. Griseofulvin: a new at an old drugs. Ann Pharmacother 1990; 24: 851-4.

8. Massa MC, Rogers RS. Griseofulvin therapy of lichen planus. Acta Derm Venereol 1981; 61: 547-50.

9. Mathews RW, Swlly C. Griseofulvin in the treatment of lichen planus: adverse drug reactions, but little beneficial effect. Ann Dent 1992; 51: 10-1.

10. Naylor GD. Treating erosive lichen planus with griseofulvin. Quintessence Int 1999; 21: 943-7.

11. Zegarelli DJ. The treatment of oral lichen planus. Ann Dent 1993; 52: 3-8.

12. Wolverton SE, ed. Comprehensive Dermatologic Drug Therapy, 2nd edn. Philadelphia: WB Saunders; 2007.

13. Bricker SL. Oral lichen planus. Semin Dermatol 1993; 13: 87-90.

14. Eison D. The therapy of oral lichen planus.Crit Rev Oral Biol Med 1993; 4: 141-9.

15. Ellgehasusen P, Elasher P, Burg G. Drugs induced lichen planus. Clin Dermatol 1998; 16: 325-32.

16. Oliver GF, Winkelman RK. Treatment of lichen planus. Drugs 1993; 45: 56-65.

17. Nasreen S, Ahmed I, Wahid Z. Association of lichen planus: A study of 63 cases. J Pak Assoc Dermatol 2007; 17: 16-20

18. Abdallat SA, Maaita TJ. Epidemiological and clinical features of lichen planus in Jordanian patients. Pak J Med Sci 2007; 23: 192-4

19. Kalmar JR. Diagnosis and management of oral lichen planus. CDA Journal 2007; 35: 405-10.

20. Taj-El-Din Anbar, Manal Barakat M, Ghannam SF. A clinical and epidemiological study of lichen planus among Egyptians of Al-Minya province. Dermatology Online J 2003; 9: 4.

21. Cribier B, Chosidow CFO. Treatment of lichen planus. Arch Dermatol 1998; 134:1521-30.

22. Sehgal VN, Abraham GJS, Malik GB. Griseofulvin therapy in lichen planus. Br J Dermatol 1972; 87: 383-5.

23. Eisen D. Hydroxychloroquine sulphate improving oral lichen planus. An open trial. J Am Acad Dermatol 1993; 28: 609-12.

24. Aufdermorte TB, De Villez RL, Gieseker DR. Griseofulvin in the treatment of three cases of oral erosive lichen planus. Oral Surg Oral Med Oral Pathol 1983; 55: 459-62.

25. Bangen JVFJ, Mestre SS, Bemejo GA, Agramont J. Treatment of lichen planus with griseofulvin report of seven cases. Oral Surg Oral Med Oral Pathol 1985; 60: 608-10.

Downloads

Published

21.12.2016

Issue

Section

Original Articles

How to Cite

1.
Comparative efficacy of hydroxychloroquine and griseofulvin in the treatment of lichen planus. J Pak Assoc Dermatol [Internet]. 2016 Dec. 21 [cited 2026 Jul. 24];20(2):79-83. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/424